MARIKO BRANDON: Open Payments
NPI 1548603673 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 79 payments from 9 companies in 2025. Trend: 2023 $1,565 · 2024 $1,330 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $210 |
| Teva Pharmaceuticals USA, Inc. | 31 | $172 |
| Vanda Pharmaceuticals Inc. | 5 | $171 |
| Supernus Pharmaceuticals, Inc. | 12 | $131 |
| Neurocrine BioSciences, Inc. | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Alkermes, Inc. | 2 | $35 |
Products named: VRAYLAR, CAPLYTA, HETLIOZ, Qelbree, INGREZZA, AUSTEDO XR, UZEDY, COBENFY.
Industry payments across FL — which companies pay providers there.
